W., Schoenherr, J., Gouker, L
The consultation was detailed and well explained with all my doubts being addressed
Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)
Second, any drug in milk barely gets into the infant's bloodstream
We postulated that 5FU treatment may promote an enhanced dependency on mitochondrial metabolism, and, in turn, mitochondrial metabolism may dictate sensitivity to 5FU